Your browser doesn't support javascript.
loading
Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study.
Ye, Li; Mei, Chen; Ren, Yanling; Zhou, Xinping; Ma, Liya; Xu, Weilai; Wei, Juying; Jiang, Huifang; Zhang, Liming; Zeng, Hui; Tong, Hongyan.
Affiliation
  • Ye L; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
  • Mei C; Key Laboratory of Hematologic Malignancies of Zhejiang Province, Hangzhou 310009, Zhejiang Province, China.
  • Ren Y; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
  • Zhou X; Key Laboratory of Hematologic Malignancies of Zhejiang Province, Hangzhou 310009, Zhejiang Province, China.
  • Ma L; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
  • Xu W; Key Laboratory of Hematologic Malignancies of Zhejiang Province, Hangzhou 310009, Zhejiang Province, China.
  • Wei J; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
  • Jiang H; Key Laboratory of Hematologic Malignancies of Zhejiang Province, Hangzhou 310009, Zhejiang Province, China.
  • Zhang L; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
  • Zeng H; Key Laboratory of Hematologic Malignancies of Zhejiang Province, Hangzhou 310009, Zhejiang Province, China.
  • Tong H; MDS Center, Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
J Cancer ; 12(10): 2975-2981, 2021.
Article in En | MEDLINE | ID: mdl-33854598

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: J Cancer Year: 2021 Document type: Article Affiliation country: China Country of publication: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: J Cancer Year: 2021 Document type: Article Affiliation country: China Country of publication: Australia